{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:15:59Z","timestamp":1753892159156,"version":"3.41.2"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Hypertrophic cardiomyopathy (HCM) is a genetic disease caused by mutations in sarcomeric proteins. Mutations in sarcomeric proteins that give rise to cardiomyopathies produce abnormalities in the biophysical properties of the sarcomere that are propagated beyond the cardiac myocyte. In this study, we evaluated the hypothesis that early desensitization of myofilament Ca<jats:sup>2+<\/jats:sup> sensitivity in the TnT-R92Q mouse model, achieved through the introduction of pseudo-phosphorylated TnI (TnI-S23,24D or TnI-DD), may delay the progression of the HCM phenotype in cardiac myocyte and endothelial cellular compartments of the heart. We studied non-transgenic mice, transgenic (TG) mice expressing TnT-R92Q (TnT-R92Q), TG mice expressing TnI-DD, and double transgenic mice expressing TnT-R92Q and TnI-DD at 28 days and 16 weeks of age. Experiments reported here demonstrate that expression of TnI-DD in the TnT-R92Q HCM mouse model results in partial normalization of myofilament Ca<jats:sup>2+<\/jats:sup> sensitivity, improved cardiac morphology and function, reduced fibrosis, normalization of YAP signaling in endothelial cells, but a lack of normalization of coronary flow parameters. The novelty of the approach reported here highlights that although small corrections made to offset the sarcomeric defect may not fully or immediately resolve the disease\u2019s pathophysiologic state, they can lessen the severity of HCM. Our findings further support the concept that early desensitization of myofilaments to Ca<jats:sup>2+<\/jats:sup> in HCM, mainly when arising from mutations in thin filament proteins, represents a promising avenue for developing new therapeutic drugs.<\/jats:p>","DOI":"10.3389\/fphys.2025.1600117","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:10:52Z","timestamp":1747973452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduction in myofilament Ca2+ sensitivity partially ameliorates the cardiac phenotype in hypertrophic cardiomyopathy linked to a TnT-R92Q mutation"],"prefix":"10.3389","volume":"16","author":[{"given":"Paulina","family":"Langa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelie","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad M.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim A. K.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Halas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Goldspink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. John","family":"Solaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata M.","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21542\/gcsp.2018.36","article-title":"The genetics of hypertrophic cardiomyopathy","volume":"2018","author":"Akhtar","year":"2018","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCGENETICS.113.000324","article-title":"Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins","volume":"7","author":"Alves","year":"2014","journal-title":"Circ. Cardiovasc Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ydbio.2018.04.026","article-title":"Endocardial Hippo signaling regulates myocardial growth and cardiogenesis","volume":"440","author":"Artap","year":"2018","journal-title":"Dev. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.117.032966","article-title":"Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy","volume":"138","author":"Axelsson Raja","year":"2018","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11010-020-03993-3","article-title":"Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice","volume":"476","author":"Batra","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.abb.2019.01.025","article-title":"Troponin I modulation of cardiac performance: plasticity in the survival switch","volume":"664","author":"Biesiadecki","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/eurheartj\/ehad637","article-title":"Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy","volume":"44","author":"Braunwald","year":"2023","journal-title":"Eur. Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/a:1023823803510","article-title":"Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61)","volume":"5","author":"Brigstock","year":"2002","journal-title":"Angiogenesis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-b","article-title":"Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography","volume":"17","author":"Camici","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"696852","DOI":"10.3389\/fphys.2021.696852","article-title":"B-arrestin-2 signaling is important to preserve cardiac function during aging","volume":"12","author":"Capote","year":"2021","journal-title":"Front. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"H705","DOI":"10.1152\/ajpheart.2001.280.2.H705","article-title":"Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T","volume":"280","author":"Chandra","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e52598","DOI":"10.3791\/52598","article-title":"Ultrasound based assessment of coronary artery flow and coronary flow reserve using the pressure overload model in mice","volume":"98","author":"Chang","year":"2015","journal-title":"J. Vis. Exp."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fphys.2020.00107","article-title":"Modifications of sarcoplasmic reticulum function prevent progression of sarcomere-linked hypertrophic cardiomyopathy despite a persistent increase in myofilament calcium response","volume":"11","author":"Chowdhury","year":"2020","journal-title":"Front. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"38938","DOI":"10.1074\/jbc.M004079200","article-title":"A single site (Ser 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to -agonists","volume":"275","author":"Chu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jchf.2023.10.004","article-title":"Exercise capacity in patients with obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM baseline characteristics and study design","volume":"12","author":"Coats","year":"2024","journal-title":"JACC Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/01.RES.0000126923.46786.FD","article-title":"Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations","volume":"94","author":"Coutu","year":"2004","journal-title":"Circ. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tcm.2021.06.001","article-title":"Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: sudden cardiac death in the young","volume":"32","author":"D'Ascenzi","year":"2022","journal-title":"Trends Cardiovasc. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1074\/jbc.M112.436311","article-title":"Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury","volume":"288","author":"Del Re","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1532-429X-14-76","article-title":"Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction","volume":"14","author":"Ellims","year":"2012","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"B22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.yjmcc.2011.07.026","article-title":"Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein","volume":"51","author":"Gaffin","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1124\/molpharm.121.000420","article-title":"Effects of sarcomere activators and inhibitors targeting myosin cross-bridges on Ca(2+)-activation of mature and immature mouse cardiac myofilaments","volume":"101","author":"Halas","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","article-title":"Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy","volume":"2","author":"Ho","year":"2009","journal-title":"Circ. Cardiovasc Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1253\/circj.CJ-24-0171","article-title":"Decoding the impact of the Hippo pathway on different cell types in heart failure","volume":"89","author":"Hu","year":"2024","journal-title":"Circ. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40265-022-01739-7","article-title":"Mavacamten: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1074\/mcp.T500024-MCP200","article-title":"Phosphate-binding tag, a new tool to visualize phosphorylated proteins","volume":"5","author":"Kinoshita","year":"2006","journal-title":"Mol. Cell Proteomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/298182a0","article-title":"Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart","volume":"298","author":"Kranias","year":"1982","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1136852","DOI":"10.3389\/fphys.2023.1136852","article-title":"Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy","volume":"14","author":"Langa","year":"2023","journal-title":"Front. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2314914121","DOI":"10.1073\/pnas.2314914121","article-title":"Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions","volume":"121","author":"Ma","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12265-009-9147-0","article-title":"Sudden death in hypertrophic cardiomyopathy","volume":"2","author":"Maron","year":"2009","journal-title":"J. Cardiovasc Transl. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.abb.2016.03.027","article-title":"Mutations in troponin T associated with hypertrophic cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation","volume":"601","author":"Messer","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/01.res.85.1.47","article-title":"Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction","volume":"85","author":"Muthuchamy","year":"1999","journal-title":"Circ. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"eabo7622","DOI":"10.1126\/sciadv.abo7622","article-title":"Mavacamten, a precision medicine for hypertrophic cardiomyopathy: from a motor protein to patients","volume":"9","author":"Nag","year":"2023","journal-title":"Sci. Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.echo.2023.11.025","article-title":"Modeling the relationship between diastolic phenotype and outcomes in pediatric hypertrophic cardiomyopathy","volume":"37","author":"Nguyen","year":"2024","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jmg-2023-109684","article-title":"Childhood-onset hypertrophic cardiomyopathy caused by thin-filament sarcomeric variants","volume":"61","author":"Norrish","year":"2024","journal-title":"J. Med. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cardfail.2023.07.003","article-title":"Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving disopyramide: REDWOOD-HCM cohort 3","volume":"29","author":"Owens","year":"2023","journal-title":"J. Card. Fail"},{"key":"B42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1469-7793.1999.0669n.x","article-title":"Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms","volume":"519","author":"Palmiter","year":"1999","journal-title":"J. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cvr\/cvv181","article-title":"Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate","volume":"108","author":"Papadaki","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.yjmcc.2010.09.010","article-title":"Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy","volume":"49","author":"Pena","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cardiores.2003.12.019","article-title":"Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts","volume":"61","author":"Pena","year":"2004","journal-title":"Cardiovasc Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"725 e721","DOI":"10.1016\/j.ahj.2005.12.005","article-title":"Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes","volume":"151","author":"Poutanen","year":"2006","journal-title":"Am. Heart J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e142446","DOI":"10.1172\/jci.insight.142446","article-title":"Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts","volume":"5","author":"Powers","year":"2020","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1074\/jbc.M409513200","article-title":"In vivo and in vitro analysis of cardiac troponin I phosphorylation","volume":"280","author":"Sakthivel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00259-016-3603-2","article-title":"Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a (13)NH(3) gated PET study","volume":"44","author":"Sciagra","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","article-title":"Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations","volume":"112","author":"Sequeira","year":"2013","journal-title":"Circ. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1038\/s44318-024-00199-x","article-title":"Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy","volume":"43","author":"Spudich","year":"2024","journal-title":"EMBO J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1074\/jbc.275.1.624","article-title":"Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy","volume":"275","author":"Szczesna","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s002590000300","article-title":"Significant regional heterogeneity of coronary flow reserve in paediatric hypertrophic cardiomyopathy","volume":"27","author":"Tadamura","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1172\/JCI6067","article-title":"Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy","volume":"104","author":"Tardiff","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B56","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjcard.2016.06.038","article-title":"Value of genetic testing for the prediction of long-term outcome in patients with hypertrophic cardiomyopathy","volume":"118","author":"van Velzen","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.devcel.2017.08.002","article-title":"YAP\/TAZ orchestrate VEGF signaling during developmental angiogenesis","volume":"42","author":"Wang","year":"2017","journal-title":"Dev. Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0003-2697(03)00350-6","article-title":"Method for cardiac myosin heavy chain separation by sodium dodecyl sulfate gel electrophoresis","volume":"320","author":"Warren","year":"2003","journal-title":"Anal. Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.yjmcc.2009.10.031","article-title":"Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?","volume":"48","author":"Willott","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/01.res.0000016962.36404.04","article-title":"Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation","volume":"90","author":"Wolska","year":"2002","journal-title":"Circ. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"ra70","DOI":"10.1126\/scisignal.2002278","article-title":"Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size","volume":"4","author":"Xin","year":"2011","journal-title":"Sci. Signal"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI17459","article-title":"Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy","volume":"111","author":"Yamamoto","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1489439","DOI":"10.3389\/fphys.2024.1489439","article-title":"Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12872-024-03859-2","article-title":"Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy","volume":"24","author":"Zhi","year":"2024","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1600117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:10:54Z","timestamp":1747973454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1600117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":64,"alternative-id":["10.3389\/fphys.2025.1600117"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2025.1600117","relation":{},"ISSN":["1664-042X"],"issn-type":[{"type":"electronic","value":"1664-042X"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"1600117"}}